Sansure

Sansure Biotech Inc. specializes in molecular diagnostics and genetic testing technologies, developing in vitro diagnostic products designed to support pathogen identification, disease diagnosis and health protection. Guided by its “Innovating Life Tech For All” commitment, the company focuses on accurate and efficient diagnostic solutions for healthcare needs.

Its portfolio includes reagents for respiratory, reproductive tract, blood-borne, gastrointestinal and vector-borne infections, along with DNA and RNA extraction reagents and sample storage products. Sansure also offers instruments such as fully automated molecular diagnostic systems, extraction equipment, PCR instruments and its mPOCT portable molecular workstation. Its solutions include immunoassay applications as well as molecular testing technologies.

The company’s technology platforms encompass one-tube fast release, advanced magnetic beads, unified automated sample processing and multiplex fluorescent PCR amplification, alongside immunological technology, high-throughput sequencing, bioinformatics and enhanced electrochemiluminescence. Sansure serves customers through its product and solution offerings, customer care, partnerships and international subsidiaries. Its website also provides company news, publications, investor information and contact resources.